SCHEMBL25329460

SCHEMBL25329460

COC(=O)c1c(C)cc(Br)cc1OC(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1I2 O75469 1/20 0.42
CYP3A4 P08684 3/20 0.41
ACHE P22303 1/20 0.41
HPGD P15428 1/20 0.40
POLB P06746 2/20 0.39
GLO1 Q04760 1/20 0.39
NOTUM Q6P988 1/20 0.38
MAPT P10636 5/20 0.36
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
PKM P14618 1/20 0.34
LMNA P02545 3/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
ALDH1A1 P00352 2/20 0.33
PTGES O14684 1/20 0.33
PTPN1 P18031 1/20 0.33
RAB9A P51151 1/20 0.33
HTT P42858 1/20 0.33
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22093026 0.85 NR1I2 (0.39) NR1I2POLBGLO1NOTUMMAPT
SCHEMBL32681270 0.84 CYP3A4 (0.36) NR1I2CYP3A4ACHEMEN1KMT2A
SCHEMBL2024646 0.82 CYP3A4 (0.49) CYP3A4ACHEHPGDPOLBGLO1
SCHEMBL29927434 0.82 CYP3A4 (0.49) CYP3A4ACHEHPGDPOLBGLO1
SCHEMBL25330411 0.81 NR1I2 (0.37) NR1I2HPGDNOTUMMEN1KMT2A
SCHEMBL610098 0.80 CYP3A4 (0.55) CYP3A4ACHEHPGDPOLBGLO1
SCHEMBL32691305 0.78 MAPK1 (0.43) NR1I2HPGDPOLBNOTUMMAPT
SCHEMBL20561922 0.77 CYP3A4 (0.42) CYP3A4ACHEHPGDPOLBGLO1
SCHEMBL32691522 0.76 ALDH1A1 (0.39) MEN1KMT2APKMLMNASMN1; SMN2
SCHEMBL17419113 0.76 CYP3A4 (0.47) CYP3A4ACHEHPGDPOLBGLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585261-A PRMT5 inhibitor, preparation method and application thereof 上海艾力斯医药科技股份有限公司 2025-03-07 CN disclosed
EP-4466260-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER Astrazeneca AB (SE) 2024-11-27 EP disclosed
CN-118574821-A Compounds and their use in the treatment of cancer 阿斯利康(瑞典)有限公司 2024-08-30 CN disclosed
WO-2024027703-A1 PRMT5 INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 上海艾力斯医药科技股份有限公司 2024-02-08 WO disclosed
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 WO disclosed
WO-2023139199-A1 COMPOUNDS AND THEIR USE IN TREATING CANCER ASTRAZENECA AB (SE) 2023-07-27 WO disclosed